Hypertrophic Cardiomyopathy: Highlights From 2021 & Genetic Testing for HCM

Published: 04 February 2022

  • Views:

    Views Icon 1590

  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating

Overview

In this hypertrophic cardiomyopathy series, Dr Carolyn Ho, presents two videos discussing highlights of 2021 and genetic testing.

Supported through an educational grant from Bristol Myers Squibb

Learning Objectives

  • Recall the efficacy and safety of existing HCM treatments
  • Summarise results from ongoing trials with experimental treatments
  • Stratify individuals with HCM signs and symptoms for subsequent investigation and / or genetic screening

Target Audience

  • Cardiologists
  • Heart failure specialists
  • Allied healthcare professionals

More from this programme

Part 1

Hypertrophic Cardiomyopathy in Review

2 sessions
Highlights of 2021 Watch now
Genetic Testing for Hypertrophic Cardiomyopathy Watch now

Faculty Biographies

Carolyn Ho

Carolyn Ho

Associate Professor

Dr Carolyn Ho is the medical director of the Cardiovascular Genetics Center at Brigham and Women’s Hospital. Dr Ho is also an associate professor of medicine at Harvard Medical School.


Dr Ho’s clinical interests include cardiomyopathy, echocardiography, and cardiovascular genetics. 

View full profile